Video LectureAACC 2014 Booth Presentation: Risk Stratification in Heart Failure - The Role of Emerging Biomarkers

Originally presented on July 27, 2014 in Chicago, Illinois.



Lecture Presenter

David G. Grenache, PhD

David G. Grenache, PhD

Medical Director, Special Chemistry Laboratory
ARUP Laboratories
Co-Director, Electrophoresis and Manual Endocrinology Laboratory
ARUP Laboratories
Chief Medical Director, Clinical Chemistry
ARUP Laboratories
Associate Professor of Pathology
University of Utah School of Medicine

Dr. Grenache is the medical director of the Special Chemistry Laboratory, a co-director of the Electrophoresis and Manual Endocrinology Laboratory, and the chief medical director of clinical chemistry at ARUP Laboratories. He is an associate professor of pathology at the University of Utah School of Medicine. Dr. Grenache earned his PhD in biomedical sciences from Worcester Polytechnic Institute in Worcester, MA and completed his postdoctoral training in clinical chemistry at Washington University School of Medicine in St. Louis, MO. Dr. Grenache is a fellow in the National Academy of Clinical Biochemistry and is board certified in clinical chemistry by the American Board of Clinical Chemistry. His research interests include reproductive biochemistry and emerging biomarkers of disease.



Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories